Publications

Found 302 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2021
Xiang C, Frietze KK, Bi Y, Li Y, Dal Pozzo V, Pal S, Alexander N, Baubet V, D'Acunto V, Mason CE et al..  2021.  RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing Neurons.. Mol Cell Biol. 41(7):e0052620.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
O'Brien DARoth, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ, Liechty B, Pisapia D, Ramakrishna R, A Wernicke G et al..  2021.  Timing of Adjuvant Fractionated Stereotactic Radiosurgery Impacts Local Control of Resected Brain Metastases.. Pract Radiat Oncol.
Tosi U, Chidambaram S, Schwarz J, Diaz SMartinez, Singh S, Norman S, Radwanski R, Murthy S, Apuzzo M, Schwartz TH et al..  2021.  The World of Neurosurgery Reimagined Post COVID-19: Crisis ↔ Opportunities.. World Neurosurg. 148:251-255.
2022
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Valenti AB, Asadourian P, Guadix S, Truong AY, Buontempo M, Hoffman CE, Souweidane M, Imahiyerobo TA.  2022.  Management of Total Frontal Bone Loss After Surgery for Craniosynostosis: The Modified Visor Bone Flap With Brain Cage.. Cleft Palate Craniofac J. :10556656221121041.
Miller AM, Szalontay L, Bouvier N, Hill K, Ahmad H, Rafailov J, Lee AJ, M Rodriguez-Sanchez I, Yildirim O, Patel A et al..  2022.  Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.. Neuro Oncol.
Miller AM, Szalontay L, Bouvier N, Hill K, Ahmad H, Rafailov J, Lee AJ, M Rodriguez-Sanchez I, Yildirim O, Patel A et al..  2022.  Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.. Neuro Oncol.
Niemeyer JE, Gadamsetty P, Chun C, Sylvester S, Lucas JP, Ma H, Schwartz TH, Aksay ERF.  2022.  Seizures initiate in zones of relative hyperexcitation in a zebrafish epilepsy model.. Brain.
2023
Mathios D, Joshua S, Bobeff EJ, Mistry AA, Schwartz AC, Dobri GA, Tabaee A, Kacker A, Anand VK, Schwartz TH.  2023.  Durable headache relief following endoscopic endonasal resection of sub-centimeter Rathke cleft cysts in medically refractory patients.. Acta Neurochir (Wien).
Rezai AR, Ranjan M, Haut MW, Carpenter J, D'Haese P-F, Mehta RI, Najib U, Wang P, Claassen DO, J Chazen L et al..  2023.  Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.. J Neurosurg. 139(1):275-283.
Mathios D, Bobeff EJ, Longo D, Nilchian P, Estin J, Schwartz AC, Austria Q, Anand VK, Godfrey KJ, Schwartz TH.  2023.  The lateral transorbital approach to the medial sphenoid wing, anterior clinoid, middle fossa, cavernous sinus, and Meckel's cave: target-based classification, approach-related complications, and intermediate-term ocular outcomes.. J Neurosurg. :1-11.
Mathios D, Bobeff EJ, Longo D, Nilchian P, Estin J, Schwartz AC, Austria Q, Anand VK, Godfrey KJ, Schwartz TH.  2023.  The lateral transorbital approach to the medial sphenoid wing, anterior clinoid, middle fossa, cavernous sinus, and Meckel's cave: target-based classification, approach-related complications, and intermediate-term ocular outcomes.. J Neurosurg. :1-11.
Hill K, Giantini-Larsen AM, Hickman RA, Holle B, Alano T, Doe-Tetteh S, Bouvier N, Li S, Stockfisch E, Huereca C et al..  2023.  Non-Invasive Diagnosis of Brainstem Gliomas in Pediatric, Adolescent, and Young Adult Patients Through Cerebrospinal Fluid Cell-Free DNA Sequencing. Neuro-Oncology. 25(Supplement 1)
Hill K, Giantini-Larsen AM, Hickman RA, Holle B, Alano T, Doe-Tetteh S, Bouvier N, Li S, Stockfisch E, Huereca C et al..  2023.  Non-Invasive Diagnosis of Brainstem Gliomas in Pediatric, Adolescent, and Young Adult Patients Through Cerebrospinal Fluid Cell-Free DNA Sequencing. Neuro-Oncology. 25(Supplement 1)
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Bobeff EJ, Mathios D, Mistry AA, Dobri GA, Souweidane MM, Anand VK, Tabaee A, Kacker A, Greenfield JP, Schwartz TH.  2023.  Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma.. J Neurosurg. 139(5):1235-1246.